Viewing Study NCT04654403


Ignite Creation Date: 2025-12-24 @ 7:09 PM
Ignite Modification Date: 2026-05-20 @ 9:06 AM
Study NCT ID: NCT04654403
Status: UNKNOWN
Last Update Posted: 2021-08-23
First Post: 2020-11-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of First-line Camrelizumab With or Without Chemotherapy for Advanced Esophageal Squamous Cell Cancer
Sponsor: The First Affiliated Hospital of Zhengzhou University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Esophageal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced or metastatic esophageal squamous cell cancer(ESCC) View